Research programme: tuberculosis DNA vaccines - GenomIdea

Drug Profile

Research programme: tuberculosis DNA vaccines - GenomIdea

Alternative Names: HVJ-Envelope/HSP65 DNA+IL-12 DNA - GenomIdea

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator GenomIdea
  • Class DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Tuberculosis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in Japan (Parenteral)
  • 17 Sep 2011 Pharmacodynamics and immunogenicity data from a Preclinical trial in Tuberculosis presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2011)
  • 15 Sep 2009 Preclinical trials in Tuberculosis in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top